Home Cart Sign in  
Chemical Structure| 68867-18-5 Chemical Structure| 68867-18-5

Structure of 68867-18-5

Chemical Structure| 68867-18-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Maryké Shaw ; Jacobus P. Petzer ; Theunis T. Cloete ; Anél Petzer ;

Abstract: Neurodegenerative disorders are caused by the progressive death of neuronal cells in specific regions of the brain and spinal cord. The most common neurodegenerative disorders are Alzheimer’s disease and Parkinson’s disease. The inhibition of enzymes that metabolise amines is an important approach in the treatment of these disorders and B inhibitors have thus been used for the treatment of Parkinson’s disease. Inhibitors of the MAO-A isoform, in turn, are used clinically for the treatment of affective (e.g., major depression) and anxiety disorders. Recent studies have shown that derivatives act as potent inhibitors. Based on these findings, the present study group synthesised thirteen derivatives and evaluated their in vitro inhibition properties. The results showed that the derivatives were potent and selective inhibitors of human MAO-B, with all compounds exhibiting IC50 values < 0.017 µM. The most potent MAO-B inhibitor (4d) had an IC50 value of 0.0046 µM, while the most potent MAO-A inhibitor (5e) had an IC50 value of 0.132 µM. It may be concluded that active derivatives may serve as potential leads for the development of inhibitors for the treatment of neuropsychiatric and neurodegenerative disorders.

Keywords: ; ; Parkinson’s disease ; Depression ; ;

Purchased from AmBeed: ;

Alternative Products

Product Details of [ 68867-18-5 ]

CAS No. :68867-18-5
Formula : C8H7NOS
M.W : 165.21
SMILES Code : OC1=CC=C2N=C(C)SC2=C1
MDL No. :MFCD00227234
InChI Key :ROFBPPIQUBJMRO-UHFFFAOYSA-N
Pubchem ID :759304

Safety of [ 68867-18-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 68867-18-5 ]

Alcohols

Chemical Structure| 68867-14-1

A394367 [68867-14-1]

2-Methylbenzo[d]thiazol-5-ol

Similarity: 0.96

Chemical Structure| 43205-00-1

A402096 [43205-00-1]

2-Methylnaphtho[1,2-d]thiazol-5-ol

Similarity: 0.95

Chemical Structure| 94977-59-0

A529799 [94977-59-0]

2-Methylbenzo[d]thiazol-4-ol

Similarity: 0.93

Chemical Structure| 1261744-69-7

A329213 [1261744-69-7]

6-Hydroxybenzo[d]thiazole-2-carbaldehyde

Similarity: 0.91

Chemical Structure| 294668-48-7

A274865 [294668-48-7]

2-Methylthieno[3',2':5,6]benzo[1,2-d]thiazol-5-ol

Similarity: 0.90

Related Parent Nucleus of
[ 68867-18-5 ]

Benzothiazoles

Chemical Structure| 68867-14-1

A394367 [68867-14-1]

2-Methylbenzo[d]thiazol-5-ol

Similarity: 0.96

Chemical Structure| 2941-72-2

A243855 [2941-72-2]

6-Methoxy-2-methylbenzo[d]thiazole

Similarity: 0.93

Chemical Structure| 94977-59-0

A529799 [94977-59-0]

2-Methylbenzo[d]thiazol-4-ol

Similarity: 0.93

Chemical Structure| 1261744-69-7

A329213 [1261744-69-7]

6-Hydroxybenzo[d]thiazole-2-carbaldehyde

Similarity: 0.91

Chemical Structure| 1176775-02-2

A419045 [1176775-02-2]

2-(Aminomethyl)benzo[d]thiazol-6-ol

Similarity: 0.90